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Toxoplasma gondii is a worldwide prevalent parasite of humans and animals. The
global infection burden exceeds yearly one million disability-adjusted life years (DALY’s)
in infected individuals. Therefore, effective preventive measures should be taken to
decrease the risk of infection in humans. Although human toxoplasmosis is predominantly
foodborne by ingestion of tissue cysts in meat from domestic animals such as pigs,
the incidence risk is difficult to estimate due to the lack of screening of animals for
infection and insights in location and persistence of the parasite in the tissues. Hence,
experimental infections in pigs can provide more information on the risk for zoonosis
based on the parasite burden in meat products intended for human consumption
and on the immune responses induced by infection. In the present study, homo- and
heterologous infection experiments with two distinct T. gondii strains (IPB-LR and
IPB-Gangji) were performed. The humoral and cellular immune responses, the presence
of viable parasites and the parasite load in edible meat samples were evaluated. In
homologous infection experiments the parasite persistence was clearly strain-dependent
and inversely correlated with the infection dose. The results strongly indicate a change in
the amount of parasite DNA and viable cysts in porcine tissues over time. Heterologous
challenge infections demonstrated that IPB-G strain could considerably reduce the
parasite burden in the subsequent IPB-LR infection. A strong, however, not protective
humoral response was observed against GRA7 and TLA antigens upon inoculation with
both strains. The in vitro IFN-γ production by TLA-stimulated PBMCs was correlated
with the infection dose and predominantly brought about by CD3+CD4−CD8αbright
T-lymphocytes. The described adaptive cellular and humoral immune responses
in pigs are in line with the induced or natural infections in mice and humans.
Jennes et al. Toxoplasma Reduction in Pigs Is Interferon-Gamma-Associated
Previous studies underscored the heterogeneity of T. gondii strains and the
corresponding virulence factors. These findings suggest the potential of the IPB-G strain
to elicit a partially protective immune response and to reduce the parasite burden upon
a challenge infection. The IPB-G strain could be used as a promising tool in limiting the
number of viable parasites in edible tissues and, hence, in lowering the risk for human
toxoplasmosis.
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INTRODUCTION
Toxoplasmosis is a parasitic infection caused by the intracellular
protozoaToxoplasma gondii. This parasite has a complex lifecycle
and affects its definitive host as well as various intermediate hosts,
among which domestic and wild animals and humans (Dubey,
2010). During its distinct developmental phases, the parasite
manifests itself as a tachyzoite, a bradyzoite or a sporozoite
in the oocyst. The sexual multiplication proceeds only within
the definitive hosts (domestic or wild members of the family
Felidae), wherein five morphologically different generations of
the gamonts develop in the enterocytes, leading to formation
of the gametocytes. Following the fertilization of the micro-
and the macrogamete and the rupture of the infected cell, the
unsporulated oocysts are discharged into the intestinal lumen.
The final hosts are responsible for the extensive shedding of
oocysts in the environment (Dubey, 1995; Afonso et al., 2008).
The sporulated oocysts containing eight sporozoites show a
high resistance to different environmental factors and under
convenient circumstances may remain infectious for 1.5 years
(Dubey, 2010). On average, the final host sheds at least one
million oocysts in the acute phase of the infection, resulting
in a massive contamination of the environment. This explains
the persistence of the parasite in wild reservoir and livestock
(Black and Boothroyd, 2000; Afonso et al., 2008; Innes, 2010;
Opsteegh et al., 2016). The sporulated oocysts release the
sporozoites upon ingestion by the intermediate host, followed
by a differentiation to tachyzoites, several cell divisions in
the enterocytes, and eventually dissemination to the peripheral
tissues. There, the fast-multiplying tachyzoites convert into tissue
cysts with the slowly dividing bradyzoites, and remain there
as the dormant stage of the infection. The predation of the
intermediate host or its tissues by the Felidae leads to the new
sexual reproduction cycle, in which the bradyzoites transform
back to tachyzoites and merozoites (Dubey, 1995; Afonso et al.,
2008).
Several infection routes have been described for the different
hosts of T. gondii; the majority of the herbivorous animals
acquires the infection through ingestion of water or plants
contaminated with oocysts. The predation of other mammals or
birds or ingestion of the placenta and/or the aborted offspring
of small ruminants facilitates the transmission of toxoplasmosis
to carnivores and omnivores (Black and Boothroyd, 2000; Innes,
2010). In humans, foodborne toxoplasmosis mainly results from
the consumption of raw or undercooked meat from infected
animals, like domestic pigs. The global prevalence of this
parasite includes one third of the human population and as
such represents one of the most common parasitic zoonosis
worldwide (Tenter et al., 2000; Ajzenberg et al., 2002; Aspinall
et al., 2002; Bosch-Driessen et al., 2002; Kijlstra and Jongert, 2008;
Innes, 2010; Robert-Gangneux and Dardé, 2012; Torgerson and
Mastroiacovo, 2013). Consequently, infection in human has a
severe short- and long-term impact, ranging from congenital or
adult toxoplasmosis in healthy individuals to T. gondii-induced
encephalitis in immune-compromised patients. In particular
congenital toxoplasmosis in seronegative pregnant women has a
very severe clinical relevance for the fetus, since the infectionmay
result in abortion, intracranial calcifications, mental retardation
or chorioretinitis in the newborn (Peyron et al., 2017). Finally,
acquired toxoplasmosis has recently been associated with an
increase in suicide rates or Parkinson’s disease (Israelski and
Remington, 1993; Holland, 2003; Lester, 2010;Miman et al., 2010;
Wang et al., 2017). Therefore, numerous preventive measures
are recommended in an attempt to decrease the global infection
burden in the human population. The commonly applied
precautions include hygienic processing of water and meat, such
as boiling of surface water and avoiding the consumption of
raw or undercooked meat, as only long term freezing at −12◦C
or baking above 67◦C can effectively deactivate tissue cysts.
Especially, pork is often consumed undercooked and is processed
inmany othermeat products, reaching on average 300 consumers
per pig (Fehlhaber et al., 2003; Belluco et al., 2016). Additionally,
direct contact with contaminated soil, plants or cat feces should
be avoided by wearing gloves when gardening or emptying
the litter box, and by thoroughly washing fresh vegetables
and fruits. Providing clear information on these preventive
measures to seronegative pregnant women, in combination with
a frequent serological screening to detect the acute infection
during pregnancy, has proven to be successful in decreasing the
infection rate (Breugelmans et al., 2004; Peyron et al., 2017). In
livestock, the preventive measures are predominantly focused on
strictly indoor housing, preventing access for cats, rodent control
and the appropriate carcass disposal (Jones and Dubey, 2012;
Robert-Gangneux and Dardé, 2012). Whereas environmental
contamination as well as the prevalence of toxoplasmosis in
sheep is overall high, the situation in regard to pigs may
vary per country or the farm management. Consequently,
the lack of uniform validation of the variety of serological
assays, and the missing gaps in the correlation between the
persistence of antibodies and parasite in pork are still to be
improved. Nevertheless, the estimated average prevalence in the
pig population seems to be very low in European countries (2.2%)
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and the USA (2.7%), presumably due to a shift from small and
less strictly confined to large scale facilities, implementing all-
in-all-out or farrow-to-finish models (Hill et al., 2008; EFSA,
2012; Guo et al., 2015). However, the recent rise of organic or
free-range farming in order to improve animal welfare seems to
contribute to an increase in infection rate in pig livestock and,
as such, to the incidence of foodborne human toxoplasmosis
(Kijlstra et al., 2004; Dubey et al., 2012; EFSA, 2012). The risk
for humans to become infected by consumption of undercooked
or raw pork is also not clear. The knowledge of the parasite
persistence in edible tissues of naturally infected pigs is limited,
as are the role of strain or dose in the parasite survival in the host.
Such information might be of pivotal importance for vaccine
development.
In the last decades numerous potential vaccine candidates
have been experimentally tested mainly in mice and to a
lesser extent in pigs. The formulations varied between a single
recombinant parasitic protein or a combination of antigens,
among which surface antigens (SAGs) or excretion/secretion
proteins (GRAs, ROPs, MICs), but also DNA vaccines encoding
B or T cell epitopes have been evaluated. However, the degrees of
success were variable and did not led to a commercial vaccine
(Vercammen et al., 2000; Letscher-Bru et al., 2003; Jongert
et al., 2008; Li et al., 2011; Cao et al., 2015; Wagner et al.,
2015). Vaccination did move forward by the use of attenuated
viable strains, which resulted with a single commercially available
vaccine for sheep, but their efficiency is tested under experimental
circumstances and strictly species-dependent, and cannot yet be
extrapolated to other livestock species or humans (Katzer et al.,
2014; Burrells et al., 2015). Nevertheless, several experimental
data in pigs reported reduction in parasite burden in infected
and subsequently heterologous challenged pigs, in which the
choice of the strain had an important effect on the viability of
the parasite (Solano Aguilar et al., 2001; Dawson et al., 2004,
2005; Kringel et al., 2004; Garcia et al., 2005; Verhelst et al.,
2011, 2015). In these studies, the involvement of the innate and
acquired immune system was observed, dominated by antibodies
production against the parasitic antigens, and by the Th1-type
of the immune response. Depending on the experimental model,
high levels of anti-GRA7 alone or anti-GRA1, -GRA7 and –TLA
IgG’s were detected upon an inoculation with IPB-G strain or
a DNA GRA1-GRA7 cocktail vaccination, followed by the RH-
strain or IPB-G challenge, respectively (Jongert et al., 2008;
Verhelst et al., 2011), whereas a challenge with heterologous M4-
strain oocysts after an experimental inoculation with viable S48-
strain tachyzoites elicited a high TLA-specific IgG production
(Burrells et al., 2015). In addition to the enhanced humoral
immunity, a polarized Th1-immune response was observed after
inoculation with a variety of the infectious T. gondii strains
(Solano Aguilar et al., 2001; Dawson et al., 2004, 2005; Jongert
et al., 2008; Verhelst et al., 2015). The significantly increased
IFN-γ protein concentration in serum and the supernatant from
the cultured PBMCs, and IFN-γ mRNA or DNA expression
in PBMCs and intestinal lymphoid tissues, appeared positively
correlated with the duration of the experiments (Solano Aguilar
et al., 2001; Dawson et al., 2004, 2005; Jongert et al., 2008;
Verhelst et al., 2015). In parallel with IFN-γ, also other cytokines
were involved in the immune response against the parasite, as
shown in the infection with the VEG-strain oocysts and the
increased secretion of IL-15 and TNF-α (Dawson et al., 2005).
Subsequently, a Th-2 response profile with predominantly IL-
10 as anti-inflammatory cytokine was observed after the early
phase of the infection, dominated by IFN-γ production, as
mentioned earlier (Solano Aguilar et al., 2001; Aliberti, 2005).
In contrast, IL-12 (IL-12p35 and IL-12p40) mRNA expression
was not detected in PBMCs shortly after inoculation (7 and 14
dpi) in another study in pigs (Dawson et al., 2005). Nonetheless,
even an excessive production of parasite-specific antibodies or
Th-1/Th2-response cytokines did not provide a full protection
during the acute phase of the infection, preventing from the cysts
formation. Despite the active role the different components of
the host’s immune system play in the early stage of T. gondii
infection, it remains a subject of discussion and ongoing research,
whether the intermediate host can clear the tissues from the cysts
on long term. It is noteworthy, however, that several studies
in pigs notified reduced or undetectable counts of the parasite
DNA in multiple porcine tissues, and a decline in viability of
the cysts, as tested by bio-assay in mice (Jongert et al., 2008;
Verhelst et al., 2011, 2015; Burrells et al., 2015). Taking into
account the lack of an obligatory screening of pigs or pork meat
to prevent transmission to humans, knowledge on the pig as an
intermediate host for T. gondii, and in particular strategies to
reduce the amount of viable parasites in tissues, may contribute to
diminishing the risk of zoonosis by consumption of porcine meat
(EFSA, 2007, 2012; Opsteegh et al., 2016). In light of these data,
the aim of this study was to confirm differences between T. gondii
strains in persistence of the parasite in tissues of experimentally
infected pigs and to relate the dose and strain to the immune
responses in the pigs upon a single infection or a heterologous
challenge.
MATERIALS AND METHODS
T. gondii Strains
Two T. gondii strains were used for the experimental infections:
the IPB-Gangji (IPB-G) strain and the IPB-LR strain. The first
one was isolated from the placenta of a patient with congenital
toxoplasmosis and is highly virulent in mice. It produces a large
number of tissue cysts and has an atypical mixed type I and
type II genotype (Ajzenberg et al., 2002). The latter was isolated
from pigs and belongs to genotype II, which is less pathogenic
and commonly present in the European pig population (Dubey,
2009; Dubey et al., 2012). Both strains are maintained at the
National Reference Laboratory for Toxoplasmosis (Scientific
Institute for Public Health, Brussels, Belgium) by passage in
Swiss female mice, since there is no alternative available to
obtain a sufficient number of tissue cysts for the inoculation
experiments than via bio-assay, as approved by the Ethical
Committee (no. 20140704-01) and conform the European
legislation (2010/63/EU). Tissue cysts from both strains were
isolated from homogenized brain tissue, counted by phase-
contrast microscopy and suspended in 10 ml of sterile phosphate
buffered saline (PBS) solution at the desired concentration (700
cysts for the low dose and 6,000 for the high dose). The animals
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were inoculated within 8 h after cysts isolation. The inoculum for
the negative control group was prepared identically from naive
Swiss mice.
Animals and Experimental Design
Two-week-old Belgian Landrace piglets were tested for the
presence of anti-T. gondii serum antibodies (IgM and IgG)
with an indirect immunofluorescence assay (IFA) as described
previously (Verhelst et al., 2015). For the infection experiments,
3-week-old newly weaned, seronegative piglets were selected and
randomly assigned to 10 groups of 3 animals (Table 1). These
groups were housed in isolation units (Biosafety permit no,
AMV/11062013/SBB219.2013/0145) at the Faculty of Veterinary
Medicine, Ghent University, Belgium. All experiments were
approved by the Ethical Committee of the faculties Veterinary
Medicine and Bioscience Engineering at Ghent University (EC
2009/149).
In a first experiment we aimed to study the effect of a low
or high infection dose of two different T. gondii strains on
the humoral and cellular immune responses and tissue cyst
persistence until 120 days after inoculation (Table 1). In a second
experiment we focused on the effect of a subsequent challenge
with a heterologous strain at 60 dpi and the persistence of
the parasite in the tissues at 120 dpi (Table 1). In study 3
we compared kinetics of the IFN-γ producing porcine T cell
subsets following infection with high doses of the IPB-G or
the IPB-LR strain until 98 dpi (Table 1). In each experiment
the peripheral blood monomorphonuclear cells (PBMCs) were
sampled at regular intervals for the detection of cytokine mRNA
by RT-qPCR, and for the quantification of the IFN-γ producing T
cell subsets, respectively. At euthanasia, PBMCs and lymphocytes
from the peripheral lymph nodes and spleen were isolated
for further in vitro assays, whereas heart, diaphragm, skeletal
muscles and brain were collected to determine the parasite
load as explained further. The experimental timeline presenting
the collected samples and the sampling intervals is shown in
Figure 1.
Humoral Immune Response
For each experiment the seroconversion was monitored during
the first 2 weeks after inoculation (wpi) by daily and subsequently
weekly blood collection from the vena jugularis until 120 days
post infection (dpi).
Antibody ELISA’s with Recombinant GRA7 and Native
TLA Antigens
As dense granule protein 7 (GRA7) is considered as a marker
of an active infection, being expressed by all T. gondii stages,
recombinant GRA7 is frequently used to demonstrate the
immune response during acute and chronic toxoplasmosis in
humans and animals (Jacobs et al., 1999). GRA7 was prepared
as previously described (Jongert et al., 2007). Briefly, GRA7
was produced as a His-tagged fusion protein by Escherichia
coli (E. coli) TOP 10 cells (Life Technologies, Ghent, Belgium)
and purified under denaturing conditions (8 M urea, 0.1%
SDS) using nickel-nitrilotriacetic acid (Ni-NTA) chelate affinity
column chromatography (Ni-NTA Superflow, Qiagen, Venlo,
The Netherlands). GRA7 was then eluted from the Ni-NTA
column using 250 mM imidazole and further purified by
sequential dialysis steps reducing the urea and SDS concentration
to 0.1 M and 0.01%, respectively.
T. gondii total lysate antigen (TLA) from tachyzoites of the
RH-strain was prepared as previously described (Jongert et al.,
2007) in the biosafety level 2 laboratory (Biosafety permit no,
415240), as approved by the Ethical Committee (no. 20140704-
01) at the National Reference Laboratory for Toxoplasmosis
(Scientific Institute for Public Health, Brussels, Belgium). TLA-
based assays show a high reactivity due to a broad range of
antigens in the lysate, however, differences in the production
method can affect the composition of the lysate (Gamble et al.,
2005; Ferra et al., 2015). Concisely, tachyzoites were diluted
with PBS and then purified by differential centrifugation and
filtration through a 5 µm syringe filter (MilleX R©SV, Merck
KGaA, Darmstadt, Germany). The tachyzoite suspension was
TABLE 1 | Experimental design: G, IPB-G strain; LR, IPB-LR strain.
Study no. Strain Dose of tissue cysts Group Number of animals Duration (dpi) Heterologous challenge (y/n)
1 G 700 Glow 3 120 No
G 6000 Ghigh 3 120 No
LR 700 LRlow 3 120 No
LR 6000 LRhigh 3 120 No
2 G 6000 Ghigh/ LRhigh 3 120 Yes (at 60 dpi)
G 6000 Ghigh1/2t 3 60 No
LR 6000 LRhigh/ Ghigh 3 120 Yes (at 60 dpi)
3 G 6000 Ghigh 3 98 No
LR 6000 LRhigh 3 98 No
Control / 0 G+LRcltr 7 120 No
Groups, a single low or high dose of the IPB-G strain (Glow and Ghigh ); a single low or high dose of the IPB-LR strain (LRlow and LRhigh ); a high dose of the IPB-G strain, followed 60 dpi
by a high dose of the IPB-LR strain (Ghigh/LRhigh); a high dose of the IPB-G strain 60 dpi (Ghigh1/2t ); a high dose of the IPB-LR strain, followed 60 dpi by a high dose of the IPB-G strain
(LRhigh/Ghigh).
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FIGURE 1 | The timeline of the experiments from the inoculation (day 0 dpi) until euthanasia (day 120 dpi). Exp, experiment; • serum for IFA, GRA- and TLA-ELISA;
N PBMCs for the quantification of IFN-γ+ T-lymphocytes by flow cytometry;  PBMCs for IFN-γ mRNA detection by qPCR.
then lysed by alternating sonication with cooling cycles using an
Ultrasonic disintegrator (MSE, Leicester, United Kingdom). To
evaluate the protein content of the lysate, the bicinchoninic acid
(BCA) reaction (Thermo Scientific Pierce BCA protein Assay
Kit, Erembodegem, Belgium) was used. Finally, the TLA was
aliquoted and stored at−20◦C until further use.
Both TLA and GRA7 were used in indirect Enzyme-Linked
Immunosorbent Assays (ELISA’s) at 10µg/ml to detect T. gondii-
specific IgM and IgG antibodies in serum samples diluted 1/50
with the goat anti-pig IgM- and IgG-Horse Radish Peroxidase
(HRP) conjugate (Bethyl Laboratories Inc., Montgomery, Texas,
USA), respectively, and 2,2′-azino-bis(3-ethylbenzothiazoline-
6-sulphonic acid (ABTS) as substrate-chromogen solution
(Verhelst et al., 2015). On each plate previously collected
sera from one positive and three negative control animals as
established by IgM and IgG immunofluorescence assay (IFA)
were included and diluted 1/50 in dilution buffer (0.05% Tween-
20 in PBS). The absorbance was measured at 405 nm (TECAN
Spectra Fluor, Tecan Group Ltd., Männedorf, Switzerland) and
the obtained data were analyzed in Microsoft Excel. Serum
samples from infected animals were considered positive when
exceeding the cut-off value calculated using the formula: mean
OD405 negative controls+ 3 x its standard deviation (SD).
Immunofluorescence Assay
The presence of IgM and IgG antibodies against T. gondii
was also evaluated by IFA using slides coated with formaline-
fixed tachyzoites from the T. gondii RH-strain (Toxo-Spot IF,
Biomérieux, Marcy-l’Etoile, France). Briefly, serum samples,
diluted 1/50 in PBS, were applied to the slides for 30 min at
37◦C, followed by washing with PBS. After drying, a second
incubation with fluorescein isothiocyanate (FITC)-conjugated
goat anti-swine IgM(µ) or IgG (H+L) (KPL, Maryland, USA)
antibody (diluted 1/25 in PBS with Evans Blue as counter dye)
was performed for 30 min at 37◦C. After washing, drying and
mounting with PBS-buffered glycerol, the slides were observed
by fluorescence microscopy (Carl Zeiss, Germany). The cut-off
read-out was established with positive and negative reference sera
at a 1/50 dilution.
Detection of the Cellular Immune
Response
PBMCs were isolated from 20 ml heparinized blood (LEO
Pharma, Ballerup, Denmark) by density gradient centrifugation
(800 × g at 18◦C, 25 min) using LymphoprepTM (Axis-
Shield, Oslo, Norway) (Sonck et al., 2010). Subsequently, the
cell pellets were resuspended in leukocyte medium [RPMI-
1640 (GIBCO BRL, Life Technologies, Merelbeke, Belgium),
supplemented with fetal calf serum (10%) (Greiner, Bio-One,
Merelbeke Belgium), non-essential amino acids (100 mM)
(Gibco), Na-pyruvate (100 µg/ml), L-glutamine (292 µg/ml)
(Gibco), penicillin (100 IU/ml) (Gibco), streptomycin (100
µg/ml) (Gibco), and kanamycin (100 µg/ml) (Gibco)]. The cells
(106 cells/well) were cultured for 6 and 72 h upon stimulation
with either TLA (10 µg/ml) as a heterologous challenge or the
mitogen concanavalin A (ConA, Sigma-Aldrich, USA; 5 µg/ml)
as a positive control.
Cytokine mRNA Quantification by RT-qPCR
After 6 h of incubation with TLA, ConA or medium, the
cells were lysed by adding 350 µl of RLT-buffer (Qiagen)
supplemented with 1% β-mercaptoethanol (99%, Thermo Fisher
Scientific, Aalst, Belgium) and stored at −80◦C until RNA
isolation. Total RNA extraction and conversion into cDNA
was performed using the RNeasy kit (Qiagen) and the iScript
kit (Biorad, Hercules, CA, USA), respectively. The purity of
the RNA was assessed by an on-column DNase digestion step
as recommended by the supplier. The amount of cytokine
cDNA was then tested by quantitative polymerase chain reaction
(qPCR). The qPCR reaction mix consisted of 12.5 µl iQ SYBR
Green Supermix (Biorad), 0.5 µl of each primer set at a
concentration of 20 µM, 1.5 µl PCR grade water and 10 µl of
the 1/100 diluted cDNA. Interleukin (IL)-10, IL-12A, IL-17A, and
interferon-gamma (IFN-γ) cDNA was amplified with the primer
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sets presented in Table 2. In order to normalize the cytokine
expression, β-actin, glyceraldehyde phosphate dehydrogenase
(GAPDH) and the ribosomal 18S gene were used as reference
genes (Table 2). Special care was taken to choose a set of primers
on different exons or spanning exon-exon junctions to exclude
the amplification of genomic DNA. The qPCR amplification
protocol consisted of an initial denaturation at 95◦C for 3 min,
followed by 45 cycles of 95◦C for 15 s and 61◦C for 20 s. After each
run, a melt curve analysis was performed to confirm the presence
of the correct amplicon and to exclude false positives due to the
formation of primer dimers. The cDNA was tested in duplicate
for each cytokine and the three reference genes (GADPH, β-actin,
r18S), showing a stable expression. The mRNA expression in
PBMCs was calculated with the CFX96 ManagerTM Software v3.1
(Biorad), using a mathematical model (delta-delta Ct method).
The mean value was determined for the target cytokines and
normalized relative to the geometric mean of the reference genes
(Verhelst et al., 2015).
Flow Cytometric Detection of IFN-γ Production
The flow cytometric detection of IFN-γ-producing proliferating
lymphocytes was performed on cultured PBMCs 72 h after
heterologous stimulation with TLA (10 µg/ml). First, the cell
division marker Violet Proliferation Dye 450 (VPD450, BD
Biosciences, Erembodegem, Belgium) was added to the isolated
mononuclear cells, showing a diminishing fluorescence after
each cell division. At the end of the incubation period, a
protein transport inhibitor, Golgi PlugTM, was added and the
cells were fixed and permeabilized using the Cytofix/CytopermTM
kit (both from BD Biosciences). Subsequently, cells were
stained using murine monoclonal antibodies (Mab) against
CD3 (IgG1, clone PPT3), CD4 (IgG2b, clone 72–14-4),
and CD8 (IgG2a, clone 11/295/33) and anti-isotype-specific
conjugates (goat anti-mouse IgG1-PerCP-Cy5.5; Santa Cruz
Biotechnology, Dallas, Texas, USA), goat anti-mouse IgG2b-
FITC (Southernbiotech, Birmingham, Alabama, USA) and goat
anti-mouse IgG2a-Alexa Fluor R©647 (InvitrogenTM, Merelbeke,
TABLE 2 | List of primers for qPCR.
Target Sequence Length amplicon (bp)
IL-10 F: CCTGGGTTGCCAAGCCTT 240
R: GCTTTGTAGACACCCCTCTCTT
IL-12A F: ACCAGCACAGTGGAGGC 95
R: CGAATGAGAGTTGCCTGGCT
IL-17A F: GGACAAGAACTTCCCTCAGCA 124
R: CTCGTTGCGTTGGAGAGTC
IFN-γ F: GAGCCAAATTGTCTCCTTCTACTT 262
R: CTGACTTCTCTTCCGCTTTCT
GAPDH F: CCATCACTGCCACCCAGAA 130
R: CAGGGATGACCTTGCCCA
B-actin F: GGCATCCTGACCCTCAAGTA 137
R: GCCTCGGTCAGCAGCA
r18S F: GTTGATTAAGTCCCTGCCCTTT 141
R: GATAGTCAAGTTCGACCGTCTT
Belgium). Finally, phycoeryrthrin (PE)-conjugated mAb against
porcine IFN-γ (Mouse IgG1, BD Biosciences) was added to
identify the lymphocyte subsets producing IFN-γ. A minimum
of 10,000 events was recorded within the proliferating cell gate
(Appendix 1). The IFN-γ secretion in the different lymphocyte
subsets was determined and compared with the results of the
isotype-matched control (Mouse IgG1-PE, Abcam, Cambridge,
UK) using a FACSAria III and FACSDIVATM software (both from
BD). The gating strategy is included in the supplementary data
(Appendix 1).
Animals were euthanized at 98 dpi and the splenocytes and
lymphocytes from the peripheral lymph nodes (mediastinal,
mesenteric and popliteal) were isolated as previously described
(Verhelst et al., 2011). Subsequently, the cells were stimulated
with the same antigens as the PBMCs for 6 h and 72 h, whereafter
the same staining occurred for flow cytometric analysis as for the
PBMCs.
Detection of the Parasite: Bio-Assay and
qPCR
In experiments 1 and 2, all animals were euthanized at 120 dpi
and the parasite load was determined in brain (Br), heart (He),
spleen, diaphragm (Di) and skeletal muscles (m. gastrocnemius
(Mg), mm. intercostales (Ic), m. longissimus dorsi (Ld), and m.
psoasmajor (Mp) by qPCR and a bio-assay. For this, 100 g of each
tissue was homogenized in 10 ml 0.85% sodium chloride (NaCl)
and digested with pepsin [0.8 g/l pepsin in 7 ml/l hydrogen
chloride (HCl)] for 1 h for brain and 2 h for the other tissues,
while stirring in a water bath at 37◦C. The obtained suspension
was filtered and centrifuged for 15 min at 1,180 × g, the
supernatant removed and the pellet resuspended in 10 ml PBS
supplemented with 40 IU/ml gentamicin. For the bio-assay, 1 ml
of the tissue suspension was inoculated intraperitoneally into 5
naive Swiss female mice. The mice were observed frequently on
a daily base for the next 5 weeks and euthanized in respect to the
human end points in case of acute toxoplasmosis associated with
suffering or reduced welfare. The surviving mice were euthanized
and tested serologically by immunofluorescence for the presence
of T. gondii IgG antibodies or by qPCR for lungs and ascites
when pre terminated due to the ethical aspects in case of acute
toxoplasmosis. To determine the parasite load by qPCRDNAwas
extracted from the tissue suspensions with the QIAamp DNA
Mini kit (Qiagen). A 10-fold serial dilution of T. gondii DNA
prepared from RH-strain tachyzoite suspension containing 106
parasites per ml was used as a standard, with a detection limit
of 2–4 tissue cysts per 100 g of tissue. Real-Time PCR (RT-PCR)
amplifying both the T. gondii repeat element (AF146527) and
the ribosomal 18S rDNA of the host cells was performed as
previously described (Rosenberg et al., 2009).
Statistics
The parasite-specific antibody and IFN-γ responses in different
groups at different time points are presented as means ± SD.
A one-way Analysis of Variance (ANOVA) was performed,
followed by post hoc Bonferroni’s and Dunnett’s Multiple
Comparison Tests for antibody production and cytokine
response, respectively, to discriminate between infected and
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control groups (GraphPad Prism 5). A p <0.05 was considered
statistically significant.
RESULTS
Parasite Burden and Immune Response
after Single Inoculation with a Low or a
High Infection Dose of the IPB-G or IPB-LR
Strain
GRA-7 and TLA-Specific Antibody Response
The GRA7-specific IgM antibodies appeared approximately at
the same time in the low and the high dose group (10 and 9
dpi, respectively) upon inoculation with the IPB-G strain and
declined gradually from 14 and 11 dpi, respectively, until 91
dpi (Figure 2A). In contrast, in the IPB-LR infected group a
pronounced IgM production was detected 8 dpi in the low dose
group and even a stronger response at 10 dpi in the high dose
group (Figure 2B), but both declined to control levels around
12 dpi. GRA7-specific IgG antibodies were detected shortly
after IgM, irrespective of the inoculation strain, and remained
detectable until the end of the experiment (Figures 2C,D).
Nevertheless, the high dose of the IPB-LR strain induced the
highest levels of GRA7-specific IgG.
TLA-specific IgM occurred earlier than GRA7-specific IgM,
namely 7 to 8 dpi in the Glow and Ghigh groups. In the latter, the
IgM response remained present until the end of the experiment,
slightly increasing in time, irrespective from the infection dose
(Figure 3A). On the contrary, for the LRlow and LRhigh groups
the seroconversion to TLA-specific IgM was prominently present
until 21 to 28 dpi, showing again the highest concentration in the
high dose group (Figure 3B). The TLA-specific IgG antibodies
appeared approximately 14 dpi in both dose groups inoculated
with the IPB-G strain (Figure 3C), but already at 8 dpi in animals
infected with the IPB-LR strain. There, the antibodies increased
significantly starting from 28 dpi and remained elevated until
FIGURE 2 | GRA7-specific IgM and IgG responses after inoculation with IPB-G or IPB-LR T. gondii strain. IgM (A,B) and IgG (C,D) responses in animals inoculated
with a low or a high dose of the IPB-G (A,C) or the IPB-LR (B,D) strain. Groups: Glow, Ghigh, LRlow, LRhigh. The horizontal dashed line indicates the cut-off value
based on the mean of the negative animals. The results represent a mean of the infected group ± SD; * (low dose vs. controls) or + (high dose vs. controls) or x (low
dose vs. high dose): P < 0.05, ** or ++ or xx: P < 0.01; *** or +++ or xxx: P < 0.001; ns, not significant.
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FIGURE 3 | TLA-specific IgM and IgG responses after inoculation with IPB-G or IPB-LR T. gondii strain. IgM (A,B) and IgG (C,D) responses in animals inoculated with
a low or a high dose of the IPB-G (A,C) or the IPB-LR (B,D) strain. Groups: Glow, Ghigh, LRlow, LRhigh. The horizontal dashed line indicates the cut-off value based
on the mean of the negative animals. The results represent a mean of the infected group ± SD; * (low dose vs. controls) or + (high dose vs. controls) or x (low dose vs.
high dose): P < 0.05, ** or ++ or xx: P < 0.01; *** or +++: P < 0.001, ns, not significant.
120 dpi (Figure 3D). In animals inoculated with the IPB-G strain
no dose effect was neither seen for TLA-specific IgM nor for
IgG production (Figures 3A,C), whereas the high dose induced
a higher response for both IgM and IgG upon inoculation with
the IPB-LR strain (Figures 3B,D). The IFA results confirmed
the seroconversion from T. gondii - negative toward IgM positive
animals and the persistence of the IgG antibodies in each
infection experiment (data not shown).
TLA-Specific IFN-γ mRNA Responses in PMBCs
PBMCs were restimulated in vitro with TLA for 6 h, where
after IL-10, IL-12A, IL-17A, and IFN-γ mRNA responses were
determined. No detectable IL-10, IL-12, and IL-17A mRNA
production was observed (data not shown) in any infected group,
irrespective of the strain or infection dose. However, a substantial
increase in IFN-γmRNA production was observed from 1month
post infection (mpi) onwards in the majority of the inoculated
animals as compared to the control animals. This response was
least pronounced in the animals infected with the low dose of
the IPB-G (not significant, p = 0.39) (Figure 4A), followed by a
significant (p < 0.01) and highly significant (p < 0.001) increase
in the high dose of the IPB-G strain group (Figure 4B). In the
low dose of the IPB-LR group we noticed a steady though not
significant (p = 0.18) increase (Figure 4C). The highest IFN-
γ production was observed in the animals infected with the
high dose of the IPB-LR strain starting from 1 mpi (p < 0.01),
which stayed high throughout the experiment, becoming highly
significant (p < 0.001) at 2, 3, and 4 mpi (Figure 4D). No
detectable IFN-γ level was detected in splenocytes from IPB-G
or IPB-LR infected animals (data not shown).
Parasite Load in Tissues
At 120 dpi, the parasite load was determined in heart and striated
skeletal muscles by qPCR and a bioassay, while in brain by qPCR
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FIGURE 4 | Relative normalized IFN-γ expression in PBMCs after a single IPB-G or IPB-LR inoculation. PBMCs were isolated monthly from pigs orally infected with
(A) a low or (B) a high dose of the IPB-G strain (Glow and Ghigh) or (C) a low or (D) a high dose of the IPB-LR strain (LRlow and LRhigh). Cells were restimulated in vitro
with TLA and IFN-γ mRNA was quantified with RT-PCR. The thick lines indicate the group mean. The significance level: **P < 0.01; ***P < 0.001.
only. In animals infected with the IPB-LR strain, the highest
parasite load was found in brain followed by heart (Table 3).
Interestingly, the inoculation dose did not affect the distribution
or load in the tissues. Besides brain and heart, also intercostal
muscles and the longissimus dorsi were consistently positive in
qPCR, whereas heart of all 6 animals was also positive in the
bioassay.
A different pattern was seen in pigs inoculated with the IPB-G
strain (Table 3), where a clear effect of the inoculation dose on
the parasite distribution and load in the tissues was found. When
inoculated with the low dose, the parasite was present in more
tissues and in higher amounts than when inoculated with the
high dose. However, even when inoculated with the low dose, the
longissimus dorsi and psoas major remained negative in all three
animals in this group. Summarizing, animals inoculated with
the high dose of IPB-G showed the lowest amount of T. gondii
DNA in their tissues. Brain, gastrocnemius and the longissimus
dorsi were negative, whereas for diaphragm and psoas major
only one sample was positive in the bioassay and qPCR,
respectively. These results strongly suggest a dose-dependent
decreased burden of the IPB-G strain in the examined tissues
following inoculation, pointing toward an immune-mediated
reduction of the parasite load.
Parasite Tissue Load and Immune
Response in a Subsequent Infection Model
with Two T. gondii Strains
In order to assess if the low parasite load observed in some tissues
after infection with the IPB-G strain was related to an immune
response, in a second experiment animals were first infected with
the high dose of one strain, followed 60 days later with the high
dose of the other strain (Table 1). Since we hypothesized an effect
of the inoculation with the IPB-G strain, an additional control
group was included in the study inoculated with the high dose at
60 dpi and 60 days before euthanasia.
GRA-7 and TLA-Specific Antibody Response
As in the first experiment, inoculation with the IPB-LR strain
induced higher GRA7- and TLA-specific IgM production than
with the IPB-G strain, independently from the order of
inoculation (Figures 5A,B). This was most pronounced for the
TLA-specific IgM response (Figure 5B). The presence of a clear
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TABLE 3 | Parasite load (number of bradyzoites per 1E+08 cells) by qRT-PCR after inoculation with two T. gondii strains, in comparison with bio-assay (number of
positive/total tested).
qPCR Bio-assay
Br Ha Di Ic Mg Ld Mp Br Ha Di Ic Mg Ld Mp
Glow 2/3 2/3 2/3 3/3 2/3 0/3 0/3 nt 2/3 1/3 1/3 0/3 0/3 0/3
Average 1.1E+05 8.5 20.6 44.6 3.0 0.0 0.0
SD 1.1E+05 8.4 29.9 13.4 2.7 0.0 0.0
Ghigh 0/3 1/3 0/3 2/3 0/3 0/3 1/3 nt 2/3 1/3 0/3 0/3 0/3 0/3
Average 0.0 1.0 0.0 21.2 0.0 0.0 2.3
SD 0.0 1.0 0.0 19.1 0.0 0.0 4.0
LRlow 3/3 3/3 3/3 3/3 2/3 3/3 3/3 nt 3/3 3/3 1/3 0/3 0/3 0/3
Average 378.78 169.63 8.46 23.45 52.40 28.67 189.07
SD 94.86 228.70 12.25 17.52 45.38 29.94 244.88
LRhigh 3/3 3/3 2/3 3/3 3/3 3/3 2/3 nt 3/3 1/3 1/3 0/3 1/3 1/3
Average 1339.97 592.25 7.82 29.4 35.0 72.6 67.8
SD 322.83 281.15 11.61 30.5 8.6 28.5 68.0
Ghigh/LRhigh 3/3 3/3 3/3 2/3 1/3 0/3 2/3 nt 3/3 2/3 1/3 0/3 0/3 1/3
Average 489.07 70.66 19.22 16.7 8.1 0.0 66.3
SD 614.04 51.02 17.93 22.3 14.1 0.0 102.2
Ghigh1/2t 2/3 3/3 1/3 0/3 1/3 1/3 0/3 nt 2/3 1/3 0/3 0/3 0/3 0/3
Average 1742.74 16.18 5.82 0.0 2.2 6.7 0.0
SD 1570.94 26.09 10.07 0.0 3.9 11.6 0.0
LRhigh/Ghigh 3/3 3/3 1/3 0/3 1/3 0/3 1/3 nt 2/3 1/3 0/3 1/3 0/3 1/3
Average 5950.50 105.32 1.67 0.0 0.8 0.0 1.6
SD 8708.45 128.54 2.90 0.0 1.5 0.0 2.7
Groups, a single low or high dose of the IPB-G strain (Glow and Ghigh ) 120 dpi; a single low or high dose of the IPB-LR strain (LRlow and LRhigh ); a high dose of the IPB-G strain, followed
60 dpi by a high dose of the IPB-LR strain (Ghigh/LRhigh); a high dose of the IPB-G strain 60 dpi (Ghigh1/2t ); a high dose of the LR strain, followed 60 dpi by a high dose of the IPB-G
strain (LRhigh/Ghigh). Tissues: Br, brain; Ha, heart; Di, diaphragm; Ic, intercostal m.; Mg, gastrocnemius m.; Ld, long. dorsi m.; Pm, poas major m.; nt, not tested.
TLA-specific IgM response after the second inoculation with the
IPB-LR strain was remarkable and suggests differences in antigen
expression between both strains (higher immunogenicity,
different antigens or other reasons), leading to the induction
of a primary immune response against various TLA antigens.
Interestingly, the increase in TLA-specific IgM levels in the IPB-
G infected animals upon initial inoculation at day 60 (Ghigh1/2t)
was higher in comparison with Ghigh or Glow groups (Figure 3A),
suggesting maturation of the immune system. Similar to our
findings of the first experiment (Figures 2C,D, 3C,D), the
GRA7- and TLA-specific IgG antibodies appeared within 2
weeks following the primary inoculation with the IPB-G or
IPB-LR strain (Figures 5C,D). A pronounced booster response
against GRA7 occurred upon the heterologous challenge at 60
dpi in both re-infected groups, as evidenced by a much faster
increase in IgG levels in contrast to animals from the Ghigh1/2t
group (Figure 5C). The TLA IgG was not boosted following the
heterologous infections in both challenged groups (Figure 5D).
However, these distinct IgG responses were more pronounced by
the challenge with the IPB-LR strain than with the IPB-G strain.
TLA-Specific IFN-γ mRNA Responses in PMBCs and
Spleen
IFN-γ responses after the initial inoculation with both T. gondii
strains (Figure 6) were comparable with those in the first
experiment (Figure 4). In two of the three animals receiving
the IPB-G strain as a first inoculation (Ghigh/LRhigh), IFN-γ
mRNA expression could not be detected 1 mpi in the PBMCs
recall assay with TLA. However, from 2 mpi all three animals
showed a significantly (p < 0.05) to highly significant (p <
0.001) increased IFN-γ mRNA level (Figure 6A), similarly to
the expression seen in animals receiving the IPB-LR strain
as a first inoculum (LRhigh/Ghigh) (Figure 6B), even though
the latter showed a more homogenous response from 1 mpi
onwards (p< 0.01). In both groups the IFN-γmRNA expressions
remained significantly elevated (p < 0.05 to p < 0.001)
during the experiment and no additional increase was seen
after inoculation with the heterologous strains. Slightly lower
yet significant (p < 0.05) IFN-γ production was observed
in group Ghigh1/2t, inoculated for the first time at 60 dpi
(Figure 6C).
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FIGURE 5 | GRA7- and TLA-specific IgM and IgG responses after inoculation with IPB-G and IPB-LR T. gondii strains. IgM (A,B) and IgG (C,D) antibody response
toward T. gondii GRA7 (A,C) and TLA (B,D) in animals after a consecutive infection with a high dose of IPB-G and IPB-LR strains. Groups: Ghigh/LRhigh,
LRhigh/Ghigh. Piglets infected after 60 days with a high dose IPB-G served as a control (Ghigh1/2t). The horizonthal dashed line indicates the cut-off value based on
the mean of the negative animals, and the vertical one the timepoint of reinfection.The results represent a mean of the infected group ± SD; * Ghigh/LRhigh vs.
controls, + LRhigh/Ghigh vs. controls, x Ghigh1/2t vs. controls, # Ghigh/LRhigh vs. LRhigh/Ghigh, ’ Ghigh/LRhigh vs. Ghigh1/2t,
◦ LRhigh/Ghigh vs. Ghigh1/2t: P < 0.05, **
or ++ or xx or ## or “ or ◦◦: P < 0.01; *** or xxx or ### or ”’ or ◦◦◦; P < 0.001; ns, not significant.
While no detectable cytokine production was found at 120
dpi in the spleen of animals from both infection groups in
the first experiment (data not shown), in the heterologous
infection model significant IFN-γ transcript levels were detected
60 days after the second infection for the Ghigh/LRhigh (p
< 0.05), Ghigh1/2t (p < 0.01), and LRhigh/Ghigh (p < 0.001)
(Figures 7A,B).
Parasite Load in Tissues
To assess the parasite load in tissues animals were euthanized
60 days after a first (Ghigh1/2t group) or second infection
(Ghigh/LRhigh and LRhigh/Ghigh groups). Interestingly, animals
receiving only the high dose of the IPB-G strain (Ghigh1/2t)
showed a parasite distribution and load (13 tissue samples
negative in a bioassay) in between those observed at 120 dpi with
the IPB-G low dose (10 tissue samples negative in a bioassay)
and the high dose (17 samples negative) in the first experiment
(Table 3). This could suggest that the reduction in parasite load
induced by the IPB-G strain was already appearing at 60 dpi upon
inoculation with the high dose. The tissue distribution at 120 dpi
in animals, which first received the IPB-LR high dose and 60
days later the IPB-G high dose, could also be explained by this
phenomenon. At 120 dpi the animals showed a different parasite
load and tissue distribution (12 samples negative) than in the first
experiment (1 and 2 samples negative after infection with the low
and the high dose, respectively). Animals receiving first the IPB-
G high dose and 60 days later the IPB-LR high dose, showed a
wider parasite tissue distribution and a higher parasite tissue load
(7 samples negative), more comparable to animals receiving only
the IPB-LR strain.
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FIGURE 6 | Relative normalized IFN-γ expression in PBMCs after a consecutive IPB-G and IPB-LR inoculation. PBMCs were isolated monthly from pigs orally
infected with (A) a high dose of the IPB-G strain followed 60 days later by a high dose of the IPB-LR strain (Ghigh/LRhigh) or (B) reversed infection model
(LRhigh/Ghigh). Piglets infected with a high dose of the IPB-G strain at day 60 served as a control (C) (Ghigh1/2t). Cells were restimulated in vitro with TLA and IFN-γ
mRNA was quantified with RT-PCR. The thick lines indicate the group mean. The significance level: *P < 0.05, **P < 0.01; ***P < 0.001.
FIGURE 7 | Relative normalized IFN-γ expression in splenocytes after a single or consecutive IPB-G and IPB-LR inoculation. Splenocytes were isolated from pigs
orally infected with (A) a low dose of the IPB-G strain (Glow), a high dose of the IPB-G strain (Ghigh), a high dose of the IPB-G strain followed 60 days later by a high
dose of the IPB-LR strain (Ghigh/LRhigh), a high dose of IPB-G at day 60 (Ghigh1/2t), or (B) a low dose of the IPB-LR strain (LRlow), a high dose of the IPB-LR strain
(LRhigh) or a high dose of the IPB-LR strain followed 60 days later by a high dose of the IPB-G strain reversed infection model (LRhigh/Ghigh). Cells were isolated at 2
mpi (group: Ghigh1/2t) or 4 mpi (groups: Glow, LRlow, Ghigh, LRhigh, Ghigh/LRhigh, LRhigh/Ghigh) and restimulated in vitro with TLA. IFN-γ mRNA was quantified with
RT-PCR. The thick lines indicate the group mean. The significance level: *P < 0.05, **P < 0.01; ***P < 0.001.
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The Involvement of CD4+ and CD8+ T Cells
in the Strain-Dependent IFN-γ Production
Results of the above experiment supported our hypothesis that
the IPB-G strain reduced the parasite burden. Since many
studies suggested an important role for IFN-γ responses in
controlling T. gondii infections, in a next experiment we
compared the kinetics of IFN-γ producing T cell subsets
in blood, following infection with the high dose of both
strains in an in vitro TLA recall assay. Depending on the T.
gondii strain, differences in the kinetics of circulating IFN-γ
producing T cell subpopulations were observed (Figure 8). The
CD3+CD4+CD8α−and CD3+CD4+CD8αdim represent porcine
T-helper cells, while CD3+CD4−CD8αbright cells are cytotoxic
T cells (Gerner et al., 2015). Animals inoculated with the
IPB-LR strain showed at 21 dpi a significant increase in the
CD3+IFN-γ+ T cell subsets (CD4+CD8α−, CD4+CD8αdim, and
CD4−CD8αbright T cells), with the CD4+CD8α− T-helper cells
(up to 22.2 ± 8.3% of CD3+IFN-γ producing cells) being most
prevalent (Figure 8A). This latter population remained stable,
whereas the CD4−CD8αbright population gradually increased
from 9.3 ± 0.87% of the IFN-γ+ producing cells at 28 dpi
to > 40% (41.1 ± 17.4%) at 98 dpi (Figure 8C). In contrast,
the percentage CD4+CD8αdimIFN-γ+ cells gradually decreased
from 16.4 ± 1.4% to <2.1 ± 0.8% at the end of the experiment
(Figure 8B). In animals inoculated with the IPB-G strain, a
similar increase in the percentage of CD4+CD8αdimIFN-γ+
cells at 21 dpi to 10.4 ± 0.4%, and a subsequent gradual
decrease to 2.2 ± 0.5% was seen (Figure 8B). The IFN-γ+
within CD4+CD8α− and CD4−CD8αbright T cells gradually
increased, reaching significantly higher levels (22.6 ± 11.9%
and 18.7 ± 9.5%, respectively) at 84 dpi as compared to 0 dpi
(Figures 8A,C). Intriguingly, the increase of the latter T cell
population was clearly less pronounced in the Ghigh (p < 0.05)
than in the LRhigh group (p < 0.01).
The difference in circulating CD4−CD8αbright T cell
populations between both high dose groups seems to be reflected
on the long term in the significantly higher (p < 0.05) percentage
of CD4−CD8αbright IFN-γ+ T cells in the popliteal lymph nodes
(LN) in the LRhigh group than in the Ghigh group at 98 dpi
(Figure 9C). Additionally, a similar difference in the percentage
of the same population between both groups can be detected in
the mesenteric LN. However, in mediastinal LN, which drain
heart and diaphragm, a higher percentage of CD4−CD8αbright
IFN-γ+ T cells was found in the Ghigh group, although not
significantly different from the LRhigh group. The distribution
of the other T cell subpopulations in different lymphoid
tissues shows a comparable pattern: a higher percentage of the
CD4+CD8α−IFN-γ+ T was found in the mesenteric (p < 0.05)
and popliteal (p > 0.05) LN of the LRhigh group than in the Ghigh
group (Figure 9A). Likewise for the CD4−CD8αbright T cells, a
reverse situation was noticed in the mediastinal LN. Regarding
the CD4+CD8αdimIFN-γ+ cells, relatively low percentages were
detected in both infected groups. The highest counts were found
in the mesenteric and popliteal LN in the LRhigh group, followed
by the mesenteric LN in the Ghigh group, whereas they were
nearly absent in the other sampled LN (Figure 9B).
FIGURE 8 | The percentage of IFN-γ+ T lymphocyte subsets in PBMCs after
a single IPB-G or IPB-LR inoculation. IFN-γ+ T lymphocyte subsets in PBMC’s
of pigs after oral infection with a high dose of the IPB-G (Ghigh) or the IPB-LR
strain (LRhigh). Cells were restimulated in vitro with TLA and demonstrated by
flow cytometry following triple staining for IFN-γ, CD3, CD4, and CD8 (A).
IFN-γ+ cell populations were identified as (A) CD3+CD4+CD8α− IFN-γ+,
(B) CD3+CD4+CD8αdim IFN-γ+, (C) CD3+CD4−CD8bright IFN-γ+
lymphocytes. The results represent mean percentages ± SD for each group; *
(IPB-G) or x (IPB-LR): P < 0.05, ** or xx: P < 0.01; *** or xxx: P < 0.001 in
comparison with day 0.
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FIGURE 9 | The percentage of IFN-γ+ T lymphocyte subsets from lymph
nodes after a single IPB-G or IPB-LR inoculation. IFN-γ+ T lymphocyte
subsets in leukocytes from peripheral lymph nodes of pigs 98 dpi with a high
dose of the IPB-G (Ghigh) or the IPB-LR strain (LRhigh). Cells were restimulated
(Continued)
FIGURE 9 | Continued
in vitro with TLA and demonstrated by flow cytometry following triple staining
for IFN-γ, CD3, CD4, and CD8 (A). IFN-γ+ cell populations were identified as
(A) CD3+CD4+CD8α− IFN-γ+, (B) CD3+CD4+CD8αdim IFN-γ+,
(C) CD3+CD4−CD8bright IFN-γ+ lymphocytes. The results represent mean
percentages ± SD for each group; *P < 0.05, **P < 0.01; ***P < 0.001.
DISCUSSION
In the performed experiments, we compared the single or
subsequent infection in pigs inoculated with either a high
or a low dose of the IPB-G and the IPB-LR strains for the
tissue specific parasite load and the accompanying immune
response. The IPB-G strain has a mixed type I/II genotype,
while the IPB-LR strain has a classic type II genotype
(Jongert et al., 2008; Dubey et al., 2012). The antibody
response against GRA7 and TLA, which are frequently used
in serological assays in different species, was monitored until
120 dpi to confirm the successful inoculation and persistence
of the infection (Figures 2, 3). Overall, for both IgM and
IgG, independent from the infection dose, the GRA7-specific
antibodies were detected very soon after the initial infection,
starting from 10 dpi (Figure 2). Similar to previous results
(Verhelst et al., 2015), we detected a late TLA-specific IgG
response from 28 to 35 dpi onwards (Figure 3). However,
results of the present study demonstrated that strain and
dose are important factors to consider, since primary GRA7-
and TLA-specific antibody responses could be detected earlier
during infection and were higher upon inoculation with a
high dose of the IPB-LR strain as compared to the IPB-
G strain. A low dose on the other hand resulted in a
later and less prominent seroconversion. Interestingly, whereas
primary antibody responses were comparable in the heterologous
challenge model, a clear IgM response was seen after the
challenge with the heterologous strains, indicating exposure to
other antigens, presumably due to the genetic diversity of both
strains (Figure 5). Burrells et al. (2015) described a significant
TLA-specific IgG increase after challenge of pigs with the
heterologous strain M4 upon inoculation with the S48 strain.
Strikingly, the challenge was performed with oocysts, after an
initial inoculation with tachyzoites, stressing the expression of
related or identical variability antigens in correlation to the
parasite stage and the strain.
Together with a robust humoral response following T. gondii
infection, a strong innate and cellular immune reaction is
well described in mouse and human models, involving several
populations of immune cells as well as different activation
pathways (Aliberti, 2005; Miller et al., 2009; Andrade et al., 2013;
Gazzinelli et al., 2014; Sturge and Yarovinsky, 2014). To date, it
is well known that innate immune cells (macrophages, dendritic
cells (DC’s) and neutrophils) are involved in the acute stage of
the infection by triggering the myeloid-differentiation primary
response protein 88 (MyD88) signaling pathway after uptake and
intracellular recognition of the parasite by CC-receptor 5 (CCR5)
or Toll-like receptor (TLR) 11 and 12 in mice; TLR7, 8, and 9
in human and TLR7 and 9 in other mammals like pigs (Miller
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et al., 2009; Andrade et al., 2013; Koblansky et al., 2013; Gazzinelli
et al., 2014). In particular interferon regulatory factor 8 (IRF8)+
dendritic cells, activated by the uptake of the parasite’s protein
profilin, are crucial for the induction of IL-12 secretion in mice.
Human and porcine DCs and monocytes are activated by the
recognition of the parasite’s ssRNA andDNA via TLR7 and TLR9,
respectively, prior to their pro-inflammatory cytokine response
(Uenishi et al., 2012; Andrade et al., 2013).
Consequently and irrespective of the activated TLRs, the DC-
driven IL-12 production leads to the activation of T-helper 1
cells and Natural Killer (NK) cells (Sturge and Yarovinsky, 2014).
The latter massively produce IFN-γ, which not only continuously
activates macrophages via a positive feedback mechanism, but
also elicits the expression of the GTPases. The GTPases family
includes four subfamilies: the very large inducible GTPases
(VLIG), the Mx proteins, the immunity-related GTPases (IRGs)
such as p47 or p65, and the guanylate-binding proteins (GBPs).
The p47 IRG offers a robust protection against intracellular
pathogens, being recruited to the parasite attachment site at
the host cell (MacMicking, 2004; Taylor et al., 2004; Liesenfeld
et al., 2011). Subsequently, a lethal damage to the parasitophorus
vacuole (PV) is induced, leading to the rupture of the infected
cell and release of the parasite into the cytosol (Gazzinelli et al.,
2014). The infected cell undergoes necrosis, simultaneously with
an enhanced local immune response. It is important to mention
that IFN-γ-inducible IRGs are well studied in murine models,
where 23 different genes have been identified to date, but the
corresponding genes are not present in the human genome,
which includes only one gene and one pseudogene (Bekpen et al.,
2005; Zhao et al., 2009). This implies that both species deploy
other intracellular defense mechanisms against T. gondii. The
data on the identification of porcine GTPases are scarce, but a
high similarity to the human IRGs is mentioned (MacMicking,
2004). Only two porcine GBPs have been reported until now:
GBP1 and GBP2, whereas in humans 7 different GBPs have
been identified (MacMicking, 2004; Li et al., 2016). More IRG’s
have been found using Affymetrix GeneChip R© Porcine Genome
Array but a detailed study in pigs is lacking (Fossum et al., 2014).
Thus, the continuous production of IFN-γ seems to be
necessary in maintaining a delicate balance between the
host immune system and the parasite’s evasion strategies.
Additionally, this cytokine plays a pivotal role in controlling
both the acute and chronic phase of infection, as it facilitates
stage conversion from the tachyzoite to the bradyzoite in
acute toxoplasmosis and suppresses the opposite conversion
during chronic infection (Denkers, 1999). Likewise, we detected
a significant increased IFN-γ production by PBMC’s after
inoculation with two different T. gondii strains (Figure 4), which
corroborates our previous results when inoculating pigs with the
IPB-G strain (Verhelst et al., 2015). Here, we demonstrated a
time- and dose-dependent increase in IFN-γ mRNA expression
upon infection with the IPB-G strain. Several studies focused
on experimental infection in pigs reported a time-dependent
increase of IFN-γ levels in serum, supernatant from cultured
PBMCs and IFN-γ mRNA expression in PBMCs and intestinal
lymphoid tissues (Solano Aguilar et al., 2001; Dawson et al., 2004,
2005; Verhelst et al., 2015).
On the contrary, the inoculation with the low dose of the IPB-
LR strain was almost as potent in inducing a relatively fast and
strong IFN-γ production by PBMCs as the high dose of the same
strain, which resulted in high IFN-γ mRNA levels at already 2
mpi, that were maintained until 120 dpi. Interestingly, the IFN-γ
mRNA production in the LRhigh dose group did not show any
increase over time, implying reaching the maximum capacity
from 1mpi onwards. In line with our findings, IL-12 (IL-12p35
and IL-12p40) mRNA expression was not detected in PBMCs in
the acute phase of the infection (7 and 14 dpi) in an earlier study
in pigs (Dawson et al., 2005).
Based on the results of the detection of IFN-γ and the
parasite DNA in tissues (Table 3), a balance between the host
defense mechanisms and the invasion of the parasite was
probably established soon after inoculation with the IPB-LR
strain. Namely, the high IFN-γ production during the infection
study was associated with the high counts of parasite DNA in
the animal tissues. On the contrary, in the IPB-G groups IFN-γ
production was elevated in the late phase of the infection and
resulted in a very low to undetectable parasite load in the tissues,
implying that high IFN-γ levels can tip the balance in favor of the
host. Intriguingly, based on our observations and unpublished
data from the acute infection model with the same strains, we
speculate that exposure to a high dose of the IPB-G strain is
more effective in activating innate immunity than the low dose
of the same strain or the inoculation with the IPB-LR strain.
The strain-dependent differences in the IFN-γ production profile
may result from the genetic and thus, biological features of the
used strains, indicating expression of variable virulence factors
toward the intermediate host. In our opinion and according to
others (Hunter and Sibley, 2012), the IPB-LR as genotype II
strain, activates other pathway than the IPB-G strain, which is
of an atypical genotype (mixed genotype I and II). The virulence
factors initiating a pathway would be GRA15 (via NF-κB) for
the former, and ROP18 (via STAT3/STAT6 pathway) for the
latter. Consequently, the IPB-LR induces Th1 type of protective
immunity and remains persistent in the chronic phase. When
looking at the IPB-LR infected groups, no substantial difference
was noticed in the IFN-γ production pattern or in the amount
of T. gondii DNA at the end of the experiment. In our view, the
IPB-LR strain does not show an acute virulence but it is adapted
to persist within the intermediate host and, as such, increase
own survival. To support these speculations, we observed a much
milder clinical manifestation upon inoculation with the IPB-LR
strain (Jennes et al., unpublished data). We further hypothesize
that resistance to the chronic infection in IPB-G model results
from the high acute virulence and the subsequent fast elimination
of the tachyzoites before they can successfully multiply and
disseminate. Consequently, fewer parasites can survive the initial
parasitemia, which eventually will lead to reduced numbers of
cysts in the tissues. Importantly, we conducted the studies in a
homogenous pig population in order to exclude host diversity;
however, as the strains are maintained by serial passage in
mice, their virulence might be altered compared to the original
isolate. Therefore, it is tempting to speculate that the high IFN-γ
production together with the lower parasite counts in the porcine
tissues originate from a coevolution toward host tolerance and
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reduced virulence, as suggested earlier by others (Gazzinelli
et al., 2014). Furthermore, looking at the total IFN-γ expression
following reinoculation with the heterologous T. gondii strain
in the second experiment, no obvious difference between the
groups could be observed (Figure 6). In the Ghigh/LRhigh group
we detected an initial increase, which was followed by a steady
decrease after the challenge. The IFN-γ production profile
in the reversed infection model (LRhigh/Ghigh) supports our
previous findings, showing a constant IFN-γ detection over time.
Interestingly, in some animals basal or low level of cytokine
mRNA were detected at 1mpi, followed by a substantial increase
at the later time points, similar to the single infection experiment
(Figures 4A, 6A). However, the final IFN-γ concentration at the
end of the experiment upon a heterologous challenge was 10
times lower than after a single high dose inoculation. We could
speculate that the primary infection with a mixed genotype I/II
strain, characterized by a high acute virulence and long-term
STAT3 and STAT6 activation, partially modulates the immune
response upon the challenge with genotype II strain. As the
result, the initial impairment of the Th1 response after the
challenge leads to a lower than in a single infection model IFN-γ
production, and elimination of a certain fraction of the parasites.
Consequently, a reduced amount of the tachyzoites disseminate
to convert into bradyzoites. The latter has been shown by a
lower parasite load 60 dpi challenge than in IPB-LR experiment
(Table 3 and Figure 6).
In regard to the involvement of immune cells in controlling
the parasite’s dissemination to the tissues and the chronic phase
of toxoplasmosis, different populations seem to play a role. As
described earlier and analogous to the acute infection stage,
the production of IFN-γ is gradually taken over from the
innate immune cells by T lymphocytes (Guan et al., 2007).
Experimental infections in mice (Jongert et al., 2010; Suzuki
et al., 2012) demonstrated the importance of CD4+ and CD8+
IFN-γ producing T cells in maintaining a chronic T. gondii
infection, but the exact contribution of each subset remains
unknown. Miller et al. (2006) describes higher production of
IFN-γ by murine CD4+ cells upon in vitro stimulation by
infected macrophages or by TLA, but admits that the higher
protective potential against dissemination of the parasite by
CD8+ or CD4+ lymphocytes is not simply expressed by the
amount of this cytokine. Indeed, it seems that IL-4 and IL-10
cytokines, produced by CD4+ lymphocytes in addition to IFN-γ,
might down regulate this protective capacity against the parasite.
In line with that, due to their IFN-γ-independent cytolytic
activity, the role of primed CD8+ T cells in the host’s immunity
during chronic toxoplasmosis has been widely acknowledged
(Wang et al., 2005; Suzuki et al., 2012; Sa et al., 2013). In
pigs, only a few experiments identified CD8+ and CD4+CD8+
cells in the acute phase of the infection as the major source
of the IFN-γ production (Solano Aguilar et al., 2001; Dawson
et al., 2005). The additive or synergistic effect of CD4+ T cells
on the activity of the CD8+ T cell population should not,
however, remain neglected. In our study, regardless of the strain,
the CD4−CD8αbright T cell subset contained the most IFN-γ
positive cells, followed by the CD4+CD8α− subset, whereas the
CD4+CD8αdim T cell subset showed very few IFN-γ positive
cells (Figure 8). Additionally, the CD4−CD8αbright population
showed a temporal increase in IFN-γ production in animals
infected with IPB-LR, while the percentage of this subset was
rather declining from 4 wpi onwards, when infected with
the IPB-G. The IFN-γ production resulting from the induced
toxoplasmosis in pigs and the involvement of the different
lymphocyte populations are in line with other studies, where
the in vitro cytokine profile was investigated until 14 (Dawson
et al., 2005), 40 (Solano Aguilar et al., 2001), or 56 dpi (Verhelst
et al., 2011). However, opposite to the pig model, in murine
experiments only two T lymphocyte subsets were differentiated
(CD4+ and CD8+). Furthermore, the extent of the cellular
response was positively correlated with the infection dose and the
time-interval from the inoculation and was higher when induced
by the strain with a greater tissue persistence. In perspective of
future experiments in pigs, it would be desirable to focus on
other immune cells, involved in the responses throughout the
infection such as the immunosuppressive T regulatory (Treg)
or Th17 cells. As recently shown in mice, the robust immune
reaction expressed by the high IFN-γ levels in the acute phase
of the infection severely reduces the activity of Tregs in a IL-2
dependent and IL-10 independent manner (Tenorio et al., 2011;
Olguin et al., 2015). In a longitudinal clinical case study of human
acquired cerebral toxoplasmosis a dual function of the Treg
population was described, by simultaneous down regulation of
CD4+ and activation of pathogen-specific CD8+ T lymphocytes
(Rb-Silva et al., 2017). In human congenital infections not only
CD4+ Treg cell population seems to be involved in the immune
reaction triggered by T. gondii, but also a different subset of
CD4+ or CD8+, namely Th17. The activity of this population
is independent from IFN-γ, IL-4 and perforin activation, as
their migration to the inflammation sites in initiated by certain
chemokines. Interestingly, the results of the in vitro PBMCs
stimulation with tachyzoites showed a higher percentage of
CD4+ IL17 producing cells above the CD8+ (Silva et al., 2014).
By investigating the fluctuations of the activity of Tregs and Th17
cells during the acute and chronic phase of the infection, we
might determine whether these populations are also involved in
the persistent immunity toward the parasite.
When considering the parasite load in the tissues and the
viability of the cysts in the bio-assay, a clear correlation was
found between the amount of detected DNA and the dose of
the used strain (Table 3). In general, we observed a decline
in the concentration of the parasite’s DNA in animals when
inoculated with a high dose of the IPB-G, but not the IPB-LR
strain. This dose- and time-dependent decline is prominently
present in different tissues in the Ghigh group in comparison with
Glow and Ghigh1/2t groups, indicating that the effect of the high
dose is particularly visible after a longer infection time. These
results are in line with the findings of Verhelst et al. (2011),
where neither parasite DNA nor viable parasites were detected
in certain muscle tissues 6 months after initial infection with the
IPB-G strain. In the same study, brain and heart of all animals
remained infectious as determined by a bio-assay and qPCR.
However, these findings are opposite to results obtained in rats
and cats, showing that inoculation with increasing amounts of
tachyzoites or bradyzoites resulted in a decreased survival rate
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or in a higher number of tissue cysts, respectively (De Champs
et al., 1998; Cornelissen et al., 2014). In addition and similar
to our results, others reported a reduction in parasite burden
in strain-vaccinated and challenged pigs (Kringel et al., 2004;
Garcia et al., 2005; Jongert et al., 2008; Burrells et al., 2015). In
these experiments vaccination with oligonucelotides, antigens or
infection with attenuated strains can enhance Th1 responses to
elicit sufficient protection during the acute phase of the infection,
resulting in a lower parasite burden in comparison with the
infected control animals. Referring to that, the strains used in our
study differ greatly in terms of genetic background and associated
virulence, both in mice and in pigs. Therefore, we have grounded
scientific reasons to believe that the observed differences in the
parasite load upon infection with both strains, especially in the
heterologous co-infection model, are not coincidental.
For most tissue samples this dose- and strain-dependent
reduction in the number of the tissue cysts in qPCR is consistent
with the bio-assay in mice. It is noteworthy that a few qPCR-
positive samples were negative in the bio-assay, indicating
that parasite DNA, but not viable parasites were present.
Consequently, these results show a substantially higher sensitivity
of the qPCR method used here above the bio-assay, since it has
been optimized and successfully applied for the detection of the
parasite in various human or animal tissues, with a detection limit
of 2–4 tissue cysts in 100 g of sample (De Craeye et al., 2011).
Conversely, both techniques gave positive results on all samples
derived from animals upon single inoculation with the IPB-LR
strain. Therefore, we can assume that the reduced parasite load
occurred due to the earlier infection with the IPB-G strain in
the group Ghigh/LRhigh. This phenomenon does not seem to be
limited to type II strains (Velmurugan et al., 2009; Suzuki et al.,
2012), but is also common in type I strains (Burrells et al., 2015).
Summarizing, the groups infected with the IPB-LR strain
can serve as a classical model of T. gondii persistence in
its intermediate host. The prominent production of parasite-
specific antibodies, consistent amounts of IFN-γ and activation
of cytotoxic T lymphocytes on the one hand and well-
distributed DNA concentration together with isolation of the
viable parasite on the other hand, clearly prove an established
balance between the host immunity and the pathogen’s activity.
The parasite’s persistence appears to be beneficial for the two,
under conditions that the immunocompetent host can resist the
immunomodulation by T. gondii. On the contrary, as the partial
or total removal of the tissue cysts was observed in the IPB-G
infected animals together with the increasing IFN-γ production
profile on both the mRNA and protein level, we propose that the
IPB-G strain induces a robust immune reaction in the host in
the early phase of the infection. This IFN-γ-mediated response
in pigs can lead to the resistance of the host to parasite invasion
by elimination of the tissue cysts during the chronic infection.
Further experiments to unravel the nature of this resistance are
warranted as it could serve an important role in vaccination
strategies and in the risk assessment for food safety and human
health.
ETHICS STATEMENT
This study was carried out in accordance with the
recommendations of the ethical standards defined by the EU
legislation on the use of laboratory animals (2010/63/EU) and
in accordance with the Belgian law (the Royal Decree 29/5/2013
and the Royal Decree 30/11/2001). The protocol was approved
by the Ethical Committee of the faculties Veterinary Medicine
and Bioscience Engineering at Ghent University (approval
number no. 176 2009/149) and by the Ethical Committee of
the WIV-ISP Institute (approval no. 176 20140704-01). The
Biosafety Level 2 permit for working with pathogens for Ugent,
Merelbeke: AMV/11062013/SBB219.2013/0145. The Biosafety
Level 2 permit for working with pathogens for WIV-IPH,
Brussels: 415240.
AUTHOR CONTRIBUTIONS
MJ designed the study, acquired and analyzed the data and
drafted the manuscript. SD designed the study, acquired, and
analyzed data and revised the manuscript. BD helped to design
the flow cytometry study and revised the manuscript. PD and KD
helped to design the study, gave valuable input and revised the
manuscript. EC designed the study, analyzed the data and wrote
the manuscript.
ACKNOWLEDGMENTS
This study was granted by the Belgian Federal Public Service
for Health, Food Chain Safety and Environment (grant RF
09/6213). The authors wish to thank A. Leremans for the
technical assistance with the bio-assay and M. Boutry for her
excellence laboratory skills with qPCR and cytokine RT-PCR.
We also wish to thank R. Cooman for the animal management.
B. Devriendt is supported by an FWO postdoctoral research
grant. The Hercules Foundation supported the purchase of
research equipment (AUGE035).
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found
online at: http://journal.frontiersin.org/article/10.3389/fcimb.
2017.00232/full#supplementary-material
REFERENCES
Afonso, E., Lemoine, M., Poulle, M. L., Ravat, M. C., Romand, S., Thulliez, P.,
et al. (2008). Spatial distribution of soil contamination by Toxoplasma gondii
in relation to cat defecation behaviour in an urban area. Int. J. Parasitol. 38,
1017–1023. doi: 10.1016/j.ijpara.2008.01.004
Ajzenberg, D., Cogne, N., Paris, L., Bessieres, M. H., Thulliez, P., Filisetti, D.,
et al. (2002). Genotype of 86 Toxoplasma gondii isolates associated with human
congenital toxoplasmosis, and correlation with clinical findings. J. Inf. Dis. 186,
684–689. doi: 10.1086/342663
Aliberti, J. (2005). Host persistence: exploitation of anti-inflammatory pathways by
Toxoplasma gondii. Nat. Rev. Immunol. 5, 162–170. doi: 10.1038/nri1547
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 17 June 2017 | Volume 7 | Article 232
Jennes et al. Toxoplasma Reduction in Pigs Is Interferon-Gamma-Associated
Andrade, W. A., Souza, M. C., Ramos-Martinez, E., Nagpal, K., Dutra, M. S., Melo,
M. B., et al. (2013). Combined action of nucleic acid-sensing Toll-like receptors
and TLR11/TLR12 heterodimers imparts resistance to Toxoplasma gondii in
mice. Cell Host Microbe 13, 42–53. doi: 10.1016/j.chom.2012.12.003
Aspinall, T. V., Marlee, D., Hyde, J. E., and Sims, P. F. (2002). Prevalence
of Toxoplasma gondii in commercial meat products as monitored by
polymerase chain reaction - food for thought? Int. J. Parasitol. 32, 1193–1199.
doi: 10.1016/S0020-7519(02)00070-X
Bekpen, C., Hunn, J. P., Rohde, C., Parvanova, I., Guethlein, L., Dunn, D. M.,
et al. (2005). The interferon-inducible p47 (IRG) GTPases in vertebrates: loss
of the cell autonomous resistance mechanism in the human lineage. Genome
Biol. 6:R92. doi: 10.1186/gb-2005-6-11-r92
Belluco, S., Mancin, M., Conficoni, D., Simonato, G., Pietrobelli, M., and Ricci,
A. (2016). Investigating the determinants of Toxoplasma gondii prevalence
in meat: a systematic review and metaregression. PLoS ONE 11:e0153856.
doi: 10.1371/journal.pone.0153856
Black, M. W., and Boothroyd, J. C. (2000). Lytic cycle of Toxoplasma gondii.
Microbiol. Mol. Biol. Rev. 64, 607–623. doi: 10.1128/MMBR.64.3.607-623.2000
Bosch-Driessen, L. E., Berendschot, T. T., Ongkosuwito, J. V., and Rothova, A.
(2002). Ocular toxoplasmosis: clinical features and prognosis of 154 patients.
Ophthalmology 109, 869–878. doi: 10.1016/S0161-6420(02)00990-9
Breugelmans, M., Naessens, A., and Foulon, W. (2004). Prevention of
toxoplasmosis during pregnancy–an epidemiologic survey over 22 consecutive
years. J. Perinat. Med. 32, 211–214. doi: 10.1515/JPM.2004.039
Burrells, A., Benavides, J., Cantón, G., Garcia, J. L., Bartley, P. M., Nath, M., et al.
(2015). Vaccination of pigs with the S48 strain ofToxoplasma gondii - safermeat
for human consumption. Vet. Res. 46:47. doi: 10.1186/s13567-015-0177-0
Cao, A., Liu, Y., Wang, J., Li, X., Wang, S., Zhao, Q., et al. (2015). Toxoplasma
gondii: vaccination with a DNA vaccine encoding T- and B-cell epitopes of
SAG1, GRA2, GRA7 and ROP16 elicits protection against acute toxoplasmosis
in mice. Vaccine 33, 6757–6762. doi: 10.1016/j.vaccine.2015.10.077
Cornelissen, J. B., van der Giessen, J. W., Takumi, K., Teunis, P. F., and Wisselink,
H. J. (2014). An experimental Toxoplasma gondii dose response challenge
model to study therapeutic or vaccine efficacy in cats. PLoS ONE 9:e104740.
doi: 10.1371/journal.pone.0104740
Dawson, H. D., Beshah, E., Nishi, S., Solano-Aguilar, G., Morimoto, M.,
Zhao, A., et al. (2005). Localized multigene expression patterns support
an evolving Th1/Th2-like paradigm in response to infections with
Toxoplasma gondii and Ascaris suum. Infect. Immun. 73, 1116–1128.
doi: 10.1128/IAI.73.2.1116-1128.2005
Dawson, H. D., Royaee, A. R., Nishi, S., Kuhar, D., Schnitzlein, W. M.,
Zuckermann, F., et al. (2004). Identification of key immune mediators
regulating T helper 1 responses in swine. Vet. Immunol. Immunopathol. 100,
105–111. doi: 10.1016/j.vetimm.2004.03.006
De Champs, C., Pelloux, H., Dechelotte, P., Giraud, J. C., Bally, N.,
and Ambroise-Thomas, P. (1998). Toxoplasma gondii infection in
rats by the RH strain: inoculum and age effects. Parasite 5, 215–218.
doi: 10.1051/parasite/1998053215
De Craeye, S., Speybroeck, N., Ajzenberg, D., Dardé, M. L., Collinet, F., Tavernier,
P., et al. (2011). Toxoplasma gondii and Neospora caninum in wildlife:
common parasites in Belgian foxes and Cervidae? Vet. Parasitol. 178, 64–69.
doi: 10.1016/j.vetpar.2010.12.016
Denkers, E. Y. (1999). T lymphocyte-dependent effector mechanisms
of immunity to Toxoplasma gondii. Microbes Infect. 1, 699–708.
doi: 10.1016/S1286-4579(99)80071-9
Dubey, J. P. (1995). Duration of immunity to shedding of Toxoplasma gondii
oocysts by cats. J. Parasitol. 81, 410–415. doi: 10.2307/3283823
Dubey, J. P. (2009). Toxoplasmosis in pigs—The last 20 years. Vet. Parasitol. 164
89–103. doi: 10.1016/j.vetpar.2009.05.018
Dubey, J. P. (2010). Toxoplasmosis of Animals and Humans, 2nd Edn. Boca Raton,
FL: CRC Press; Taylor and Francis Group.
Dubey, J. P., Hill, D. E., Rozeboom, D. W., Rajendrana, C., Choudharya, S.,
Ferreira, L. R., et al. (2012). High prevalence and genotypes of Toxoplasma
gondii isolated from organic pigs in northern USA. Vet. Parasitol. 188, 14–18.
doi: 10.1016/j.vetpar.2012.03.008
EFSA (2012). European Food Safety Authority, European Centre for Disease
Prevention and Control; The European Union Summary Report on Trends and
Sources of Zoonoses, Zoonotic Agents and Food-borne Outbreaks in 2010. The
EFSA Journal 10:2597. 442. doi: 10.2903/j.efsa.2012.2597
EFSA (2007). Scientific Opinion of the Panel on Biological Hazards on a request
from, EFSA on Surveillance and monitoring of Toxoplasma in humans, foods
and animals. EFSA J. 583, 1–64. doi: 10.2903/j.efsa.2007.583
Fehlhaber, K., Hintersdorf, P., and Kruger, G. (2003). Study on the prevalence of
Toxoplasma gondii in pigs of different management systems and in minced
meat. Fleischwirtschaft 83, 97–99.
Ferra, B., Holec-Ga˛sior, L., and Kur, J. (2015). Serodiagnosis of Toxoplasma
gondii infection in farm animals (horses, swine, and sheep) by enzyme-linked
immunosorbent assay using chimeric antigens. Parasitol. Int. 64, 288–294.
doi: 10.1016/j.parint.2015.03.004
Fossum, C., Hjertner, B., Ahlberg, V., Charerntantanakul, W., McIntosh, K.,
Fuxler, L., et al. (2014). Early inflammatory response to the saponin
adjuvant Matrix-M in the pig. Vet. Immunol. Immunopathol. 158, 53–61.
doi: 10.1016/j.vetimm.2013.07.007
Gamble, H. R., Dubey, J. P., and Lambillotte, D. N. (2005). Comparison of
a commercial ELISA with the modified agglutination test for detection of
Toxoplasma infection in the domestic pig. Vet. Parasitol. 128, 177–181.
doi: 10.1016/j.vetpar.2004.11.019
Garcia, J. L., Gennari, S. M., Navarro, I. T., Machado, R. Z., Sinhorini, I. L., Freire,
R. L., et al. (2005). Partial protection against tissue cysts formation in pigs
vaccinated with crude rhoptry proteins of Toxoplasma gondii. Vet. Parasitol.
129, 209–217. doi: 10.1016/j.vetpar.2005.01.006
Gazzinelli, R. T., Mendonça-Neto, R., Lilue, J., Howard, J., and Sher, A. (2014).
Innate resistance against Toxoplasma gondii: an evolutionary tale of mice, cats,
and men. Cell Host Microbe 15, 132–138. doi: 10.1016/j.chom.2014.01.004
Gerner, W., Talker, S. C., Koinig, H. C., Sedlak, C., Mair, K. H., and
Saalmüller, A. (2015). Phenotypic and functional differentiation of porcine
αβT cells: current knowledge and available tools. Mol. Immunol. 66, 3–13.
doi: 10.1016/j.molimm.2014.10.025
Guan, H., Moretto, M., Bzik, D. J., Gigley, J., and Khan, I. A. (2007). NK cells
enhance dendritic cell response against parasite antigens via NKG2D pathway.
J. Immunol. 179, 590–596. doi: 10.4049/jimmunol.179.1.590
Guo, M., Dubey, J. P., Hill, D., Buchanan, R. L., Gamble, H., Jones, J. L., et al.
(2015). Prevalence and risk factors for Toxoplasma gondii infection in meat
animals and meat products destined for human consumption. J. Food Prot. 78,
457–476. doi: 10.4315/0362-028X.JFP-14-328
Hill, D. E., Haley, C., Wagner, B., Gamble, H. R., and Dubey, J. P.
(2008). Seroprevalence of and risk factors for Toxoplasma gondii in the
US swine herd using sera collected during the National Animal Health
Monitoring Survey (Swine 2006). Zoonoses Public Health 57, 53–59.
doi: 10.1111/j.1863-2378.2009.01275.x
Holland, G. N. (2003). Ocular toxoplasmosis: a global reassessment. Part I:
epidemiology and course of disease. Am. J. Ophthalmol. 136, 973–988.
doi: 10.1016/j.ajo.2003.09.040
Hunter, C. A., and Sibley, L. D. (2012). Modulation of innate immunity by
Toxoplasma gondii virulence effectors. Nat. Rev. Microbiol. 10, 766–778.
doi: 10.1038/nrmicro2858
Innes, E. A. (2010). A brief history and overview of Toxoplasma gondii. Zoonoses
Public Health 57, 1–7. doi: 10.1111/j.1863-2378.2009.01276.x
Israelski, D. M., and Remington, J. S. (1993). Toxoplasmosis in
patients with cancer. Clin. Inf. Dis. 17(Suppl. 2), S423–S435.
doi: 10.1093/clinids/17.Supplement_2.S423
Jacobs, D., Vercammen, M., and Saman, E. (1999). Evaluation of recombinant
dense granule antigen 7 (GRA7) of Toxoplasma gondii for detection of
immunoglobulin G antibodies and analysis of a major antigenic domain. Clin.
Diagn. Lab. Immunol. 6, 24–29.
Jones, J. L., and Dubey, J. P. (2012). Foodborne toxoplasmosis. Clin. Infect. Dis. 55,
845–851. doi: 10.1093/cid/cis508
Jongert, E., De Craeye, S., Dewit, J., and Huygen, K. (2007). GRA7 provides
protective immunity in cocktail DNA vaccines against Toxoplasma gondii.
Parasite Immunol. 29, 445–453. doi: 10.1111/j.1365-3024.2007.00961.x
Jongert, E., Lemiere, A., Van Ginderachter, J., De Craeye, S., Huygen, K., and
D’Souza, S. (2010). Functional characterization of in vivo effector CD4+ and
CD8+ T cell responses in acute Toxoplasmosis: an interplay of IFN-gamma
and cytolytic T cells. Vaccine 28, 2556–2564. doi: 10.1016/j.vaccine.2010.01.031
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 18 June 2017 | Volume 7 | Article 232
Jennes et al. Toxoplasma Reduction in Pigs Is Interferon-Gamma-Associated
Jongert, E., Melkebeek, V., De Craeye, S., Dewit, J., Verhelst, D., and Cox,
E. (2008). An enhanced GRA1-GRA7 cocktail DNA vaccine primes
anti-Toxoplasma immune responses in pigs. Vaccine 26, 1025–1031.
doi: 10.1016/j.vaccine.2007.11.058
Katzer, F., Canton, G., Burrells, A., Palarea-Albaladejo, J., Horton, B., Bartley, P.
M., et al. (2014). Immunization of lambs with the S48 strain of Toxoplasma
gondii reduces tissue cyst burden following oral challenge with a complete strain
of the parasite. Vet. Parasitol. 205, 46–56. doi: 10.1016/j.vetpar.2014.07.003
Kijlstra, A., Eissen, O. A., Cornelissen, J., Munniksma, K., Eijck, I., and Kortbeek, T.
(2004). Toxoplasma gondii infection in animal-friendly pig production systems.
Invest. Ophthalmol. Vis. Sci. 45, 3165–3169. doi: 10.1167/iovs.04-0326
Kijlstra, A., and Jongert, E. (2008). Control of the risk of human
toxoplasmosis transmitted by meat. Int. J. Parasitol. 2008, 1359–1370.
doi: 10.1016/j.ijpara.2008.06.002
Koblansky, A. A., Jankovic, D., Oh, H., Hieny, S., Sungnak, W., Mathur,
R., et al. (2013). Recognition of profiling by Toll-like receptor 12 is
critical for host resistance to Toxoplasma gondii. Immunity 38, 119–130.
doi: 10.1016/j.immuni.2012.09.016
Kringel, H., Dubey, J. P., Beshah, E., Hecker, R., and Urban, J. F. Jr. (2004). CpG-
oligodeoxynucleotides enhance porcine immunity to Toxoplasma gondii. Vet.
Parasitol. 123, 55–66. doi: 10.1016/j.vetpar.2004.01.021
Lester, D., (2010). Brain parasites and suicide. Psychol. Rep. 107:424.
doi: 10.2466/12.13.PR0.107.5.424
Letscher-Bru, V., Pfaff, A. W., Abou-Bacar, A., Filisetti, D., Antoni, E., Villard, O.,
et al. (2003). Vaccination with Toxoplasma gondii SAG-1 protein is protective
against congenital toxoplasmosis in BALB/c mice but not in CBA/J mice. Infect.
Immun. 71, 6615–6619. doi: 10.1128/IAI.71.11.6615-6619.2003
Li, J., Huang, X., Zhang, G., Gong, P., Zhang, X., and Wu, L. (2011).
Immune response and protective efficacy against homologous challenge
in BALB/c mice vaccinated with DNA vaccine encoding Toxoplasma
gondii actin depolymerizing factor gene. Vet. Parasitol. 179, 1–6.
doi: 10.1016/j.vetpar.2011.03.003
Li, L. F., Yu, J., Li, Y., Wang, J., Li, S., Zhang, L., et al. (2016). Guanylate-
binding protein 1, an interferon-induced GTPase, exerts an antiviral activity
against classical swine fever virus depending on its GTPase activity. J. Virol. 90,
4412–4426. doi: 10.1128/JVI.02718-15
Liesenfeld, O., Parvanova, I., Zerrahn, J., Han, S.-J., Heinrich, F., Muñoz, M., et al.
(2011). The IFN-γ-Inducible GTPase, Irga6, protects mice against Toxoplasma
gondii but not against Plasmodium berghei and some other intracellular
pathogens. PLoS ONE 6:e20568. doi: 10.1371/journal.pone.0020568
MacMicking, J. D. (2004). IFN-inducible GTPases and immunity to intracellular
pathogens. Trends Immunol. 25, 601–609. doi: 10.1016/j.it.2004.08.010
Miller, C. M., Boulter, N. R., Ikin, R. I., and Smith, N. C. (2009). The
immunobiology of the innate response to Toxoplasma gondii. Int. J. Parasitol.
39, 23–39. doi: 10.1016/j.ijpara.2008.08.002
Miller, R., Wen, X., Dunford, B., Wang, X., and Suzuki, Y. (2006). Cytokine
production of CD8+ immune T cells but not of CD4+T cells from Toxoplasma
gondii-infected mice is polarized to a type 1 response following stimulation
with tachyzoite-infected macrophages. J. Interferon Cytokine Res. 26, 787–792.
doi: 10.1089/jir.2006.26.787
Miman, O., Kusbeci, O. Y., Aktepe, O. C., and Cetinkaya, Z. (2010). The probable
relation between Toxoplasma gondii and Parkinson’s disease. Neurosci. Lett.
475, 129–131. doi: 10.1016/j.neulet.2010.03.057
Olguin, J., Fernández, J., Salinas, N., Terrazas, L., and Saavedra, R. (2015).
Reduction of regulatory T cells during acute Toxoplasma gondii infection is
caused by IFN-γ (MPF2P.759). J. Immunol. 194(Suppl. 1) 63.18. Available
online at: http://www.jimmunol.org/content/194/1_Supplement/63.18
Opsteegh, M., Schares, G., and van der Giessen, J., on behalf of the consortium
(2016). Relationship between seroprevalence in the main livestock species
and presence of Toxoplasma gondii in meat (GP/EFSA/BIOHAZ/2013/01). An
extensive literature review. Final report. EFSA Supporting Publication 2016:EN-
996:294.
Peyron, F., Mc Leod, R., Ajzenberg, D., Contopoulos-Ioannidis, D., Kieffer, F.,
Mandelbrot, L., et al. (2017). Congenital Toxoplasmosis in France and the
United States: one parasite, two diverging approaches. PLoS Negl. Trop. Dis.
11:e0005222. doi: 10.1371/journal.pntd.0005222
Rb-Silva, R., Nobrega, C., Reiriz, E., Almeida, S., Sarmento-Castro, R., Correia-
Neves, M., et al. (2017). Toxoplasmosis-associated IRIS involving the CNS: a
case report with longitudinal analysis of T cell subsets. BMC Infect Dis. 17:66.
doi: 10.1186/s12879-016-2159-x
Robert-Gangneux, F., and Dardé M.-L. (2012). Epidemiology of and
Diagnostic Strategies for Toxoplasmosis. Clin. Microbiol. Rev. 25, 264–296.
doi: 10.1128/CMR.05013-11
Rosenberg, C., De Craeye, S., Jongert, E., Gargano, N., Beghetto, E., Del Porto, P.,
et al. (2009). Induction of partial protection against infection with Toxoplasma
gondii genotype II by DNA vaccination with recombinant chimeric tachyzoite
antigens. Vaccine 27, 2489–2498. doi: 10.1016/j.vaccine.2009.02.058
Sa, Q., Woodward, J., and Suzuki, Y. (2013). IL-2 produced by CD8+ immune
T cells can augment their IFN-γ production independently from their
proliferation in the secondary response to an intracellular pathogen. J.
Immunol. 190, 2199–2207. doi: 10.4049/jimmunol.1202256
Silva, J. L., Rezende-Oliveira, K., da Silva, M. V., Gómez-Hernández, C.,
Peghini, B. C., Silva, N. M., et al. (2014). IL-17-expressing CD4+ and CD8+
T lymphocytes in human toxoplasmosis. Mediators Inflamm. 2014:573825.
doi: 10.1155/2014/573825
Solano Aguilar, G. I., Beshah, E., Vengroski, K. G., Zarlenga, D., Jauregui, L., Cosio,
M., et al. (2001). Cytokine and lymphocyte profiles in miniature swine after
oral infection with Toxoplasma gondii oocysts. Int. J. Parasitol. 31, 187–195.
doi: 10.1016/S0020-7519(00)00159-4
Sonck, E., Stuyven, E., Goddeeris, B., and Cox, E. (2010). The effect of b-
glucans on porcine leukocytes. Vet. Immunol. Immunopathol. 135, 199–207.
doi: 10.1016/j.vetimm.2009.11.014
Sturge, C. R., and Yarovinsky, F. (2014). Complex Immune Cell Interplay in
the Gamma Interferon Response during Toxoplasma gondii Infection. Infect.
Immun. 82, 3090–3097. doi: 10.1128/IAI.01722-14
Suzuki, Y., Sa, Q., Gehman, M., and Ochiai, E. (2012). Interferon-gamma- and
perforin-mediated immune responses for resistance against Toxoplasma gondii
in the brain. Expert Rev. Mol. Med. 13:e31. doi: 10.1017/S1462399411002018
Taylor, G. A., Feng, C. G., and Sher, A. (2004). p47 GTPases: regulators of immunity
to intracellular pathogens.Nat. Rev. Immunol. 4, 100–109. doi: 10.1038/nri1270
Tenorio, E. P., Fernández, J., Castellanos, C., Olguín, J. E., and Saavedra, R. (2011).
CD4+ Foxp3+ regulatory T cells mediate Toxoplasma gondii-induced T-cell
suppression through an IL-2-related mechanism but independently of IL-10.
Eur. J. Immunol. 41, 3529–3541. doi: 10.1002/eji.201141507
Tenter, A. M., Heckeroth, A. R., and Weiss, L. M. (2000). Toxoplasma
gondii: from animals to humans. Int. J. Parasitol. 30, 1217–1258.
doi: 10.1016/S0020-7519(00)00124-7
Torgerson, P. R., and Mastroiacovo, P. (2013). The global burden of congenital
toxoplasmosis: a systematic review. Bull. World Health Organ. 91, 501–508.
doi: 10.2471/BLT.12.111732
Uenishi, H., Shinkai, H., Morozumi, T., and Muneta, Y. (2012). Genomic
survey of polymorphisms in pattern recognition receptors and their possible
relationship to infections in pigs. Vet. Immunol. Immunopathol. 148, 69–73.
doi: 10.1016/j.vetimm.2011.07.019
Velmurugan, G. V., Su, C., and Dubey, J. P. (2009). Isolate designation and
characterization of Toxoplasma gondii isolates from pigs in the United States. J.
Parasitol. 95, 95–99. doi: 10.1645/GE-1746.1
Vercammen, M., Scorza, T., Huygen, K., De Braekeleer, J., Diet, R., Jacobs, D.,
et al. (2000). DNA vaccination with genes encoding Toxoplasma gondii antigens
GRA1, GRA7, and ROP2 induces partially protective immunity against lethal
challenge in mice. Infect. Immun. 68, 38–45. doi: 10.1128/IAI.68.1.38-45.2000
Verhelst, D., De Craeye, S., Jennes,M., Dorny, P., Goddeeris, B., and Cox, E. (2015).
Interferon-gamma expression and infectivity of Toxoplasma infected tissues
in experimentally infected sheep in comparison with pigs. Vet. Parasitol. 207,
7–16. doi: 10.1016/j.vetpar.2014.11.014
Verhelst, D., De Craeye, S., Melkebeek, V., Goddeeris, B., Cox, E., and Jongert,
E. (2011). IFN-γ expression and infectivity of Toxoplasma infected tissues are
associated with an antibody response against GRA7 in experimentally infected
pigs. Vet. Parasitol. 179, 14–21. doi: 10.1016/j.vetpar.2011.02.015
Wagner, A., Schabussova, I., Ruttkowski, B., Peschke, R., Kur, J., Kundi, M.,
et al. (2015). Prime-boost vaccination with Toxoplasma lysate antigen,
but not with a mixture of recombinant protein antigens, leads to
reduction of brain cyst formation in BALB/c mice. PLoS ONE 10:e0126334.
doi: 10.1371/journal.pone.0126334
Wang, X. J., Claflin, H., Kang, Y., and Suzuki (2005). Importance of
CD8+Vbeta8+ T cells in IFN-gamma-mediated prevention of toxoplasmic
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 19 June 2017 | Volume 7 | Article 232
Jennes et al. Toxoplasma Reduction in Pigs Is Interferon-Gamma-Associated
encephalitis in genetically resistant BALB/c mice. J. Cytokine Res. 25, 338–344.
doi: 10.1089/jir.2005.25.338
Wang, Z. D., Liu, H. H., Ma, Z. X., Ma, H. Y., Li, Z. Y., Yang, Z.
B., et al. (2017). Toxoplasma gondii infection in immunocompromised
patients: a systematic review and meta-analysis. Front. Microbiol. 8:389.
doi: 10.3389/fmicb.2017.00389
Zhao, Y. O., Khaminets, A., Hunn, J. P., and Howard, J. C. (2009).
Disruption of the Toxoplasma gondii parasitophorous vacuole by
IFNc-Inducible Immunity-Related GTPases (IRG Proteins) triggers
necrotic cell death. PLoS Pathog. 5:e1000288. doi: 10.1371/journal.ppat.
1000288
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2017 Jennes, De Craeye, Devriendt, Dierick, Dorny and Cox. This
is an open-access article distributed under the terms of the Creative Commons
Attribution License (CC BY). The use, distribution or reproduction in other forums
is permitted, provided the original author(s) or licensor are credited and that the
original publication in this journal is cited, in accordance with accepted academic
practice. No use, distribution or reproduction is permitted which does not comply
with these terms.
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 20 June 2017 | Volume 7 | Article 232
